Published in Cancer Weekly, April 17th, 2006
According to recent research published in the International Journal of Molecular Medicine, "[We] aimed to elucidate the mechanism responsible for the interactive effects of HDAC inhibitors [suberoylanilide hydroxamic acid (SAHA), MS-275, m-carboxycinnamic acid bishydroxamide (CBHA), and trichostatin-A (TSA)] and TRAIL on apoptosis in leukemia cells."
"HDAC inhibitors enhance...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.